NJBIZ reveals 2024 Leaders in Real Estate, Construction and Design honorees njbiz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from njbiz.com Daily Mail and Mail on Sunday newspapers.
Investegate announcements from Westport Fuel Systems Inc, Westport Announces Plan to Invest Up to $10 Million USD in Global Manufacturing Facility in Changzhou Hydrogen Valley, China
Read Time:
Cobra Biologics, the gene therapy division of the Cognate BioServicesâ group, has today announced a multi-phase augmentation of its plasmid DNA services as a continuation of its Gene Therapy servicesâ expansion project for viral vectors and plasmid DNA. This includes a four-fold increase in HQ (High Quality) DNA manufacturing capacity alongside new clinical and commercial GMP DNA facilities at its European facilities. The HQ plasmid manufacturing service provides a rapid six-week delivery time for the clinical manufacture of immuno-oncology therapies, for example products utilizing AAV, lentiviral vector and CRISPR products.
After its acquisition of Cobra Biologics in January 2020, Cognate has positioned itself as a global provider of end-to-end capabilities in the development and manufacturing of cell & gene therapy products. This expansion is in direct response to the great demand of commercial capacity within the biologics industry.